Moleculin to Begin Clinical Trials at UMC Southwest Cancer Center
May 16, 2018 08:30 ET
|
Moleculin Biotech, Inc.
HOUSTON, May 16, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
Moleculin Biotech, Inc. Reports Financial Results for the First Quarter Ended March 31, 2018
May 15, 2018 08:30 ET
|
Moleculin Biotech, Inc.
HOUSTON, May 15, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...
Moleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial
May 03, 2018 08:30 ET
|
Moleculin Biotech, Inc.
HOUSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug...